Systemic mastocytosis emerging after azacitidine treatment of refractory anaemia with excess blasts type 2
Suspicious mammographic masses in the breast: splenosis in an unusual body site due to a remote ballistic trauma
A new hope: novel therapeutic approaches to treatment of chronic lymphocytic leukaemia with defects in TP53
Diagnosing and following adult patients with acute myeloid leukaemia in the genomic age
Paclitaxel, topotecan and rituximab: long term outcomes of an effective salvage programme for relapsed or refractory aggressive B-cell non-Hodgkin lymphoma
A phase 1 clinical trial of vorinostat in combination with decitabine in patients with acute myeloid leukaemia or myelodysplastic syndrome
The bone marrow stromal compartment in multiple myeloma patients retains capability for osteogenic differentiation in vitro : defining the stromal defect in myeloma
90Y-ibritumomab tiuxetan radiotherapy as first-line therapy for early stage low-grade B-cell lymphomas, including bulky disease
Telomere dysfunction accurately predicts clinical outcome in chronic lymphocytic leukaemia, even in patients with early stage disease
Italian external and multicentric validation of the MD Anderson Cancer Center nomogram and prognostic index for chronic lymphocytic leukaemia patients: analysis of 1502 cases
SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemia
Histopathological features and their prognostic impact in nodular lymphocyte-predominant Hodgkin lymphoma – a matched pair analysis from the German Hodgkin Study Group (GHSG)
A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study)
Red blood cells of sickle cell disease patients exhibit abnormally high abundance of N-methyl D-aspartate receptors mediating excessive calcium uptake
CD4-positive small T-cell lymphoma of the intestine presenting with severe bile-acid malabsorption: a supportive symptom control approach
A novel L1340P mutation in the ANK1 gene is associated with hereditary spherocytosis?
Small molecule enhancers of rapamycin induce apoptosis in myeloma cells via GSK3A/B preferentially within a protective bone marrow microenvironment
Oral anticoagulant agent-associated bleeding events reporting system (ORANGE) study
JAK2 V617F and CALR mutations are not mutually exclusive; findings from retrospective analysis of a small patient cohort
A robust molecular pattern for myelodysplastic syndromes in two independent cohorts investigated by next-generation sequencing can be revealed by comparative bioinformatic analyses
Molecular subtype classification of formalin-fixed, paraffin-embedded diffuse large B-cell lymphoma samples on the ICEPlex® system
Unexplained anaemia in the elderly is characterised by features of low grade inflammation